Cardiac rehabilitation in atrial fibrillation: a protocol for a Danish survey and registry-based study (PRIME-AF) Authors: Caroline Matilde Elnegaard, Britt Borregaard, Signe Stelling Risom, Claus Tveskov, Mickael Bech, Jacob von Bornemann Hjelmborg, Jesper Eilsø, Anne Marie Hedegaard, Annemie Stege Bojer, Stine Darkner, Andi E Albertsen, Albert Marni Joensen, Axel Brandes, Ann-Dorthe Zwisler Published: 2025 ABSTRACT AbstractIntroductionAtrial fibrillation (AF) is a growing public health concern associated with significant morbidity, mortality and impaired quality of life. Despite evidence supporting cardiac rehabilitation (CR) as part of secondary prevention in AF care, referral rates remain low, and the extent of CR needs in this population is unknown. This protocol outlines a nationwide survey-based and registry-based study aiming to: i) describe CR needs among individuals with AF and ii) assess eligibility and acceptance of referral to specific CR components based on individual patient preferences and their overlap with identified needs.Methods and analysisThis cross-sectional study includes three phases: 1) identification of the study population using Danish national registries; 2) electronic survey distribution to individuals with a first-time AF diagnosis in 2023–2024 and 3) registry data enrichment of the entire population. The survey includes validated patient-reported outcome measures aligned with a newly developed Needs Assessment Model, supplemented by items on patient preferences for CR components. Data are analysed descriptively and using correlation analysis.Ethics and disseminationParticipants are informed of the study purpose, data protection and their rights before providing informed consent through survey participation. The study follows the Declaration of Helsinki and Danish ethical standards. Findings are disseminated via scientific journals, conferences, a cross-sectoral stakeholder workshop and public outreach activities.Trial registration numberNCT06772207. STRENGTHS AND LIMITATIONS OF THIS STUDY This nationwide study combines patient-reported outcomes with high-quality registry data, ensuring representability and large statistical power. This nationwide study combines patient-reported outcomes with high-quality registry data, ensuring representability and large statistical power. The study links patient-reported needs with patient preferences for specific cardiac rehabilitation components, providing novel, important and clinically relevant knowledge for future AF management. The study links patient-reported needs with patient preferences for specific cardiac rehabilitation components, providing novel, important and clinically relevant knowledge for future AF management. The survey captures lifestyle and well-being factors not available in registries, but the electronic-only format and survey length may reduce participation and introduce selection bias. The survey captures lifestyle and well-being factors not available in registries, but the electronic-only format and survey length may reduce participation and introduce selection bias. The cross-sectional design prevents causal inference and does not capture potential changes in cardiac rehabilitation needs over time. The cross-sectional design prevents causal inference and does not capture potential changes in cardiac rehabilitation needs over time. We expect that this is the largest national survey on systematic needs assessment using patient-reported outcomes among individuals with AF, offering data that can inform resource allocation, capacity building and more individual tailored cardiac rehabilitation pathways in this growing population. We expect that this is the largest national survey on systematic needs assessment using patient-reported outcomes among individuals with AF, offering data that can inform resource allocation, capacity building and more individual tailored cardiac rehabilitation pathways in this growing population. Introduction Atrial fibrillation (AF) is the most common cardiac arrhythmia in adults globally, with a prevalence of 2–4%.1 2 By the age of 55, there is a lifetime risk of one in three individuals.1 2 AF is increasing in both high-income countries and middle-income countries. It poses significant public health challenges because of an ageing population and increasing comorbidity.3 4 AF is associated with morbidity and mortality, causing a significant burden on the healthcare systems worldwide. It also affects the individual’s quality of life (QoL) negatively with symptoms like palpitations, dyspnoea and fatigue, and many report high levels of anxiety and depression.2510 To improve life expectancy and QoL, the management of AF has traditionally focused on stroke prevention, cardiovascular treatment and rate and rhythm control.1 2 A number of risk factors and comorbidities are associated with the development and progression of AF, such as increasing age, coronary artery disease, hypertension, diabetes, heart failure, obstructive sleep apnoea (OSA), smoking and obesity.1 2 Given the cost and potential complications related to medications and treatments (e.g. catheter ablation) of AF, accurate evaluation and management of symptoms, risk factors and functional status are crucial. Studies show that patient education and comprehensive risk factor management may improve QoL, reduce AF burden and risk of hospitalisations.1119 The 2024 ESC guidelines emphasise a patient-centred, holistic, multidisciplinary, integrated care approach for AF management (AF-CARE). This approach highlights the importance of treating comorbidities and risk factors as key to AF management. Several of these elements align with cardiac rehabilitation (CR) and secondary prevention interventions, like lifestyle changes and patient education.1 The integrated care approach has been arising internationally,12 2022 including in Denmark.11 In Denmark, as in other Western countries, CR as part of secondary prevention has largely moved from hospitals to the primary care sector in the local communities.23 24 This came without AF-specific guidelines,15 25 leading to gaps in implementation, unknown eligibility, unknown resource use and low referral rates. According to the most recent Danish Atrial Fibrillation Database report, only 16% of individuals with AF receive patient education within 1 year after their AF onset, while the recommended standard is at least 50%.26 Low referral rates are also seen in other western countries and in low-income countries.27 28 These referral patterns exist despite the evidence showing important health benefits of CR for individuals with AF.29 Thus, AF care calls for systematic needs assessment and referral procedures to provide individual, tailored and integrated care, including CR for this rapidly growing and chronic disease. A model for systematic needs assessment (later referred to as “The Needs Assessment Model”) has been developed through an international Delphi process30 31 and can be used to assess needs. We do not know how many individuals with AF would be accepting a referral based on patient preferences for CR components. Importantly, CR is not a single standardised programme, but rather a collection of components tailored to the individual patient—therefore patient preferences are important to consider. Core components typically include patient education, psychosocial support, supervised physical exercise, alcohol counselling, dietary intervention and occupational guidance, as well as management of risk factors (eg, smoking, obesity, hypertension, diabetes, etc.). However, in AF, patient-reported needs and patient preferences for CR components remain poorly described. This article presents a protocol for a large, nationwide survey-based and registry-based study in the AF population that will i) describe the needs for CR as part of secondary prevention among individuals with AF based on a newly published needs assessment model, and ii) assess eligibility and acceptance of referral to specific CR components based on individual patient-preferences and their overlap with identified needs. Methods and analysis The study is registered at ClinicalTrials.gov (NCT06772207) and is reported following the international statement in the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist for cross-sectional studies.32 Study design The study is a cross-sectional survey-based and registry-based study and includes three phases: 1) the definition of the target population through registry data; 2) the electronic survey sent to eligible participants; and 3) enrichment of the entire dataset with additional registry data. Danish health registries hold data on every person with a unique and personal 10-digit identification number (the ‘CPR number’),33 which is given to every resident in Denmark at birth or immigration.34 The registries provide healthcare and demographic data.3537 They do not provide data on lifestyle, risk factors and health behaviours, which are better collected by population health surveys.38 Phase 1 – definition of the population The Danish Civil Registration System (CRS)36 is used to define the population and find eligible respondents for the study. The CRS holds individual information on every Danish resident including date of birth, sex, place of birth, citizenship, identity of parents and continuously updated information on vital status, place of residence and civil status. For this purpose, the CRS data are linked with data from the Danish National Patient Registry (NPR)37 and the Danish Nursing Home Registry (PLH) via the CPR number. The NPR holds information about all hospital contacts including diagnoses, diagnostic and treatment procedures during the last 40 years. The PLH holds information about citizens living in Danish nursing homes. Inclusion and exclusion criteria All Danish residents with a first-time diagnosis of AF between 1 January 2023 and 31 December 2024 (ICD-10 diagnosis code: DI48*) are eligible. Incident AF is defined as a first ICD-10 coded diagnosis of AF during 2023–2024, with no prior AF diagnosis recorded in the NPR since the introduction of ICD-10 in 1994. This approach provides a 29-year wash-out period. Exclusion criteria are used in the following order: 1) death; 2) <18 years of age; 3) living in a nursing home; 4) individuals receiving palliative care or treatment (procedure code (SKS code): BXB*) from 2019 and onwards, as we expect that these people are in the final phase of their life and receive other support from either a nursing home or hospice facilities; 5) a diagnosis of dementia from 2013 and onwards (ICD-10 diagnosis codes: DF00*-DF03*, DG30*); or 6) hospital admissions or ambulant contacts due to mental illness (except anxiety and depression) within 1 year prior to AF diagnosis (ICD-10 diagnosis codes: DF04*-DF29* and DF50*-DF99*) for mortality reasons; and 7) individuals who are non-contactable, that is, in name and address protection, individuals registered under guardianship, individuals with invalid addresses or individuals not living in Denmark. Furthermore, individuals exempted from using their electronic mailbox (e-books, government electronic mail account) are excluded as the survey will only be administered online. Phase 2 – the survey A full survey proposal was developed in mid-2024, guided by the previously mentioned international Delphi process, developing the Needs Assessment Model,30 reflecting important criteria for a thorough evaluation of CR needs. While the overall survey has not yet undergone psychometric validation as a composite measure, it is based on the Delphi consensus process and contains multiple, validated, health-related questionnaires, also called patient-reported outcome measures (PROMs). The survey proposal was also reviewed and revised through a Patient and Public Involvement (PPI) process (see below) towards the end of 2024 to ensure relevance and clarity. Final agreement on survey content was reached in January 2025. Survey send-out via REDCap (Research Electronic Data Capture) software with planned electronic reminders in June 2025. Survey close-down in December 2025. REDCap provides secure data storage (a licence agreement has been made with Odense Patient Data Explorative Network (OPEN) in the Region of Southern Denmark (project number OP_1718)). Eligible respondents’ personal identification number is imported to REDCap and used for survey distribution to the participants’ electronic mailbox. Information about the study is provided in the invitation along with the survey link. A reminder invitation is sent after 2 weeks. The survey content is described in online supplemental table S1. Table 1 provides an overview of the content of the data collection for the needs assessment criteria. In general, we sought PROMs validated in a Danish version, with as few items as possible, typically using Likert scales. Most of the items were predefined as ‘required’ answering; however, some were optional, for example, text boxes and a few additional items for specific sub-groups. Online supplemental table S1 holds this information. In addition, the survey also contains a question on whether the respondent would be interested in taking up specific CR or prevention interventions if offered (eg, patient education, psychosocial support, physical exercise, alcohol counselling, dietary intervention, smoking cessation, etc.). These responses are used to explore patient preferences against which PROM-based needs can be compared. Table 1Content of the data collection: PROMs and registry dataNeeds assessment criteriaSource: PROM or registry dataPROMs tool or registry sourceRegistry data time periodBinary cut-offs for all criteria indicating need for CRAtrial fibrillation related quality of lifePROMASTA HRQoL57 58Scale scores are calculated where values range from 0 toHigher scores reflect a worseeffect on HRQoL due to arrhythmia.Cut-off will be further explored as part of the descriptive analysis.Atrial fibrillation-related symptom burdenPROMAF-659The scale ranges from 0 to 10 on a Likert scale, where 0 means no and 10 means severe symptoms or difficulties. The scores of the six questions are added into a single global score.Cut-off will be further explored as part of the descriptive analysis.Anxiety: General well-being and anxiety symptomsPROMWHO-5 + ASS-260WHO-5: Scores below 50 indicate poor well-being. ASS-2: higher score of ASS-2 indicates a higher symptom level of anxiety.We will use the cross-walks table to convert to the Hospital Anxiety and Depression Scale (HADS) and use a binary understanding of cut-offs (0–7 normal/no anxiety, ≥8 anxiety symptoms present and indication for referral to CR components. 60Note that a score ≥11 should also lead to further investigation in general practice.Medication adherencePROMMARS-561Score individual items (5=never to 1=always) i.e. high scores=high adherence. Add the individual scores together to form a scale score (range=5 to 25). Calculate an adjusted mean score by dividing the scale mean by the number of items in the scale (range 1–5).Scores can be used binary with a cut-off ≤24 indicating medication adherence.62Physical (in)activityPROMPRO-Heart-DK63 64Physical inactivity.Smoking habitsPROMPRO-Heart-DK63 64Active smoking.Alcohol consumption habitsPROMPRO-Heart-DK63 64International AF guidelines1: ≤3 units per week.Height and weight (BMI for obesity)PROMCountry Health Profile65BMI≥27.Sleep apnoeaPROM/RegistrySTOP-Bang score66 67, with information on sex, age and hypertension from registry dataNowHigh risk of sleep apnoea by ‘yes’ to >4 items in STOP-Bang.HypertensionRegistryNPR37/ LSR431994àDiagnosis=yes, or being treated with drugs for hypertension=yesDiabetes or pre-diabetesRegistryNPR37/ LSR431994àDiagnosis=yes, or being treated with drugs for diabetes=yesCardiac comorbiditiesRegistryNPR371994àDiagnosis=yesBMI, body mass index; CR, cardiac rehabilitation; HRQoL, Health-related quality of life; LSR, Danish National Prescription Registry; NPR, Danish National Patient Registry; PROM, patient-reported outcome measures. Content of the data collection: PROMs and registry data BMI, body mass index; CR, cardiac rehabilitation; HRQoL, Health-related quality of life; LSR, Danish National Prescription Registry; NPR, Danish National Patient Registry; PROM, patient-reported outcome measures. Phase 3 – Enrichment of the survey data with additional registry data Danish health registry data are used to enrich the entire dataset and to assess potential non-response bias. Specifically, registry data will enable comparisons of responders and non-responders on a wide range of demographic, socioeconomic and clinical characteristics. These include demographic variables (age, sex, civil status, living situation (living alone or with someone), place of living (Danish region) and immigration status) and socioeconomic indicators (educational level, occupational status and income), obtained from the OPEN registry database (OPEN RDB),39 which functions under Statistics Denmark (DST),40 and holds data from well-known registries like the CRS.36 Comorbidity profiles are measured using the Charlson Comorbidity Index41 and the Nordic Comorbidity Index,42 based on data from the NPR37 and the Danish National Prescription Registry (LSR).43 Treatment-related data such as cardioversion, ablation, anticoagulants, rhythm control therapy, pacemaker and current CR services (patient education, physical exercise, dietary interventions and smoking cessation) are identified using NPR procedure codes from the Danish Medical Classification System (SKS).37 Data enrichment is conducted during spring 2026 to ensure highest possible data completeness for the entire population. By systematically comparing responders and non-responders across these variables, we will evaluate the representativeness of the survey population and assess the extent and potential impact of non-response bias. Any observed differences are discussed as a limitation when interpreting survey results. Sample size considerations In Denmark, approximately 22 000 Danish citizens have a first-time diagnosis of AF each year.26 44 Using data from 2 years, the incident population is around 44 000 individuals. Applying the described exclusion criteria, the eligible population will expectedly decrease to about 24 600 individuals. We anticipate a response rate of approximately 35% based on the following assumptions: 1) AF being a condition of the elderly and diseased population with a tendency of lower response rates45 46 and 2) the growing reluctance to answer surveys in the general population with a tendency to lower response rates from 2020 (61%)4749 to 2023 (41%).50 51 Based on these assumptions, approximately 8600 individuals (35%) will respond to the survey. Figure 1 shows the expected flowchart of the study. Expected flowchart of the study. AF, atrial fibrillation. Patient and public involvement (PPI) In this study, PPI has occurred in the planning phase as well as in the development and pilot testing of the survey. The pilot testing of the survey and adjustments is described in table 2, based on the GRIPP2-SF (short form) checklist.52 Table 2The PPI process and alterations related to pilot-testing the surveyGRIPP2-SF checklistThis studyTopicDescription and alterationsAimThe aim of the PPI process was to get the survey tested and reviewed by individuals with AF and experienced researchers (called the PPI group). This is an important step before sending a survey.MethodsWe began by distributing a survey draft, online and by paper, to the PPI group, who tested, reviewed and commented on it. They were asked to focus on the length and PROM composition, the information letter, technical aspects of the survey and providing general feedback. The PPI group was assembled for a meeting in December 2024 where the survey draft was discussed.Study resultsThis resulted in the survey being shortened, focusing on ‘need to know’ and ‘nice to know’. Some PROMs were excluded (stress, loneliness). Informational texts were shortened. And, there was a focus on the choice of wording for the AF diagnosis, to keep it close to the general public.The PPI group received the revised survey for a second piloting and acknowledged the survey lengths and revisions in January 2025. Thereafter, the survey was finalised.Discussion and conclusionThe PPI process influenced the study by ensuring that the survey in total was relevant, understandable, technically functional and could be completed within an acceptable timeframe. It also contributed to greater face- and content validity of the survey.Reflections and critical perspectiveThe PPI process was positively experienced by the PPI group.PPI, Patient and public involvement. The PPI process and alterations related to pilot-testing the survey PPI, Patient and public involvement. Statistical analyses Descriptive statistics will be used to characterise the study population and describe their reported CR needs. Variables reflecting needs will be summarised as counts and percentages. PROM total-scores and sub-scores (continuous variables) will be assessed for normality and summarised as means and SD or medians and IQRs, as appropriate. To assess acceptance of referral to specific CR components, participants’ self-reported ‘interest in taking up specific CR or prevention interventions if offered’, will be reported descriptively for each CR component. The preferences will be examined descriptively and visualised using bar charts and Venn diagrams. Overlap between needs assessment criteria and patient preferences is evaluated descriptively (needs yes/no X patient preferences yes/no). A sensitivity analysis will be performed to estimate the potential impact of non-response. First, the proportion of respondents reporting each CR need will be applied to the non-respondents group under the assumption that the distribution of needs is similar among responders and non-responders. The estimate will then be adjusted to age and sex using registry data. The adjusted proportions will be combined to provide population-level estimates of CR needs in the full AF cohort. All analyses will be conducted using Stata (StataCorp, College Station, TX). Ethics and dissemination The study is registered at the Region of Southern Denmark’s record of data processing activities (22/28369) and approved by the Regional Committees on Health Research Ethics for Southern Denmark (20222000–24). All participants are informed of the study and survey purpose, use of data, data protection and related laws, consent, participation, voluntariness, anonymity, analysis and dissemination of results. By answering the survey, they will voluntarily give their informed consent to participate in the study. The participants are able to contact the study group via e-mail. The study complies with ethical principles for medical research as described in the Declaration of Helsinki and with the practices of the Danish National Committee on Health Research Ethics.53 Study results, regardless of whether they are positive, negative or neutral, are disseminated via peer-reviewed scientific journals and presentations at national and international conferences as well as to the broader public. Healthcare professionals will also be invited to a cross-sectoral workshop where study results are shared and discussed. Discussion and perspectives This study addresses a significant knowledge gap in AF management by describing the specific CR needs of individuals with AF based on a systematic needs assessment model and assessing eligibility and acceptance of referral to specific CR components based on patient preferences. By combining PROM data with registry information, this study will deliver nuanced insights into CR needs and patient preferences towards CR components. These results can inform the healthcare system regarding resource allocation, guide the development of flexible and modular CR programmes and support primary care providers in systematically assessing AF-related needs. Ultimately, a more structured approach to needs assessment could improve patient outcomes, enhance quality of life and reduce healthcare burdens by lowering rates of hospitalisation and complications related to untreated risk factors. Thus, the study aligns with the 2024-ESC AF guidelines, which emphasise an integrated, patient-centred approach to AF care, including risk factor modification and comorbidity management alongside traditional treatment strategies such as stroke prevention and rhythm control.1 Despite the rising prevalence of AF worldwide and the strong evidence linking lifestyle and risk factor management to improved outcomes, few CR programmes specifically target individuals with AF. Consequently, referral and uptake rates remain low in Denmark and other countries.2629 We introduce a framework that illustrates how needs assessment criteria can be linked to specific CR components, such as patient education, psychosocial support, physical exercise, etc. This framework may serve as a model for future analyses and can guide structured referral procedures. By quantifying not only overall needs but also the distribution of needs across CR components, future studies can provide evidence for capacity building and systematic referral that ensure individuals receive the most relevant support based on their needs. This knowledge has particular importance for primary care, where management of chronic conditions such as AF increasingly takes place. Hence, this knowledge may potentially be applicable to the design of tailored programmes and the allocation of healthcare resources in the future. While this study will provide a valuable snapshot of needs and patient preferences related to CR components, future research should estimate the eligible population for each specific CR component. Knowledge is needed that provides a detailed overview of the CR components that are most likely required for individuals with AF. Future research should also identify thresholds for the needs assessment criteria that do not already have validated, well-established cut-offs, in addition to evaluating implementation of systematic and structured needs assessments in clinical settings. This includes testing how the framework can be operationalised, exploring cost-effectiveness and evaluating patient adherence and outcomes, when interventions are matched to needs. Framework of needs assessment criteria relating to specific CR components. Strengths and limitations The study has several strengths. First, it is a nationwide investigation combining survey and registry data, providing high representability and large statistical power. Denmark’s comprehensive and accurate registry data is a key strength: identifying individuals with incident AF through NPR is highly valid, with a positive predictive value (PPV) of 95% for AF.54 Furthermore, registry data enable detailed characterisation of both responders and non-responders, thereby minimising loss to follow-up and reducing risk of selection bias. This allows systematic evaluation of non-response bias. Second, the survey complements registry data by collecting crucial information not available through registries, including lifestyle factors, well-being and patient preferences for CR. The majority of PROMs used are validated Danish instruments, with a mix of generic and AF-specific instruments. The survey content was guided by an international Delphi process and refined through PPI, strengthening its face validity and patient relevance. Despite these strengths, several limitations should be acknowledged. First, the survey is subject to potential recall bias, selection bias and non-response. Although registry data allow comparison of responders and non-responders on a broad range of demographic, socioeconomic and clinical factors, non-response bias cannot be fully eliminated. Certain factors influencing survey participation (eg, patient motivation, digital literacy or language barriers) are not captured in registries. This limitation is considered when interpreting survey results. Second, the electronic survey format may exclude individuals with limited IT literacy, though evidence suggests that paper-based alternatives do not significantly improve participation.47 Individuals with high symptom burden or fatigue may also be less likely to respond,55 potentially leading to underrepresentation of those most in need of CR. Third, while the survey includes multiple validated PROMs, the combined survey has not been formally validated as a composite measure. However, its development through Delphi consensus and refinement through PPI mitigates this concern.56 Fourth, the cross-sectional design limits causal inference, and it is possible that CR needs vary over time after diagnosis, making it important to analyse CR needs based on the year of diagnosis. Fifth, certain groups were excluded (eg, nursing home residents, individuals with severe mental illness or those receiving palliative care) for ethical reasons, as CR interventions are unlikely to be relevant for them. This exclusion slightly reduces the eligible population but does not limit the generalisability of findings to the broader AF population. Sixth, AF cases were identified using ICD-10 codes with a wash-out period covering 1994–2022. Some individuals diagnosed with AF during the ICD-8 era (1977–1993) or prior to immigration to Denmark may thus be misclassified as incident cases. However, this number is expected to be very small and unlikely to affect our results. Finally, while PROMs and registry data provide valuable insights into CR needs, they cannot fully replace individualised clinical consultations, where needs are explored and matched to interventions in dialogue with healthcare professionals. Supplementary material